Baxalta to Present at Credit Suisse Healthcare Conference

BANNOCKBURN, Ill.--(BUSINESS WIRE)-- Baxalta Incorporated (NYSE: BXLT) announced today that it will present at the Credit Suisse Healthcare Conference on Wednesday, Nov. 11, 2015, at 12:30 p.m. Central Time.

The live webcast of Baxalta’s presentation along with the accompanying slides will be accessible from the Baxalta corporate website at investor.baxalta.com.

About Baxalta

Baxalta Incorporated (NYSE: BXLT) is a $6 billion global biopharmaceutical leader developing, manufacturing and commercializing therapies for orphan diseases and underserved conditions in hematology, oncology and immunology. Driven by passion to make a meaningful impact on patients’ lives, Baxalta’s broad and diverse pipeline includes biologics with novel mechanisms and advanced technology platforms such as gene therapy. The Baxalta Global Innovation and R&D Center is located in Cambridge, Massachusetts. Launched in 2015 following separation from Baxter International, Baxalta’s heritage in biopharmaceuticals spans decades. Baxalta’s therapies are available in more than 100 countries and it has advanced biological manufacturing operations across 12 facilities, including state-of-the-art recombinant production and plasma fractionation. Headquartered in Northern Illinois, Baxalta employs 16,000 employees worldwide.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151102005032/en/

Baxalta Media Relations
Geoffrey Mogilner, +1-224-940-8619
[email protected]
or
Baxalta Investor Relations
Mary Kay Ladone, +1-224-948-3371
[email protected]
or
Lorna Williams, +1-224-948-3511
[email protected]

Source: Baxalta Incorporated

You May Also Be Interested In

• Aarion Capital LP Marks Six Months Since Launch With Inaugural Performance Report and Continued Institutional Development
• ASIA'S 50 BEST BARS UNVEILS THE EXTENDED 51-100 LIST FOR 2026
• Samsung Becomes a Sisvel Wi-Fi Multimode Pool Licensee and Licensor